dog
given
nonmyeloabl
condit
marrow
graft
dog
leukocyt
antigen
dla
ident
litterm
donor
develop
stabl
trichimer
stabli
accept
subsequ
kidney
graft
one
marrow
donor
without
need
immunosuppress
studi
use
trichimera
evalu
strategi
adopt
immunotherapi
solid
tumor
use
kidney
tumor
surrog
three
dlaident
trichimer
recipi
establish
simultan
infus
marrow
dlaident
donor
dog
dlaident
recipi
condit
gy
total
bodi
irradi
tbi
given
short
cours
postgraft
immunosuppress
stabl
hematopoiet
engraft
confirm
kidney
transplant
marrow
donor
respect
trichimer
recipi
peripher
blood
lymphocyt
kidney
donor
use
sensit
altern
marrow
donor
trichimer
recipi
given
donor
lymphocyt
infus
dli
sensit
dog
monitor
chimer
graftversushost
diseas
gvhd
kidney
reject
dli
observ
prompt
reject
transplant
marrow
donor
kidney
disappear
correspond
hematopoiet
chimer
presum
due
share
minor
histocompat
antigen
host
chimer
also
disappear
gvhd
skin
gut
liver
develop
nativ
kidney
although
exhibit
lymphocyt
infiltr
remain
function
normal
studi
demonstr
certain
experiment
condit
kidneyan
organ
ordinarili
involv
graftversushost
reactionscan
target
sensit
donor
lymphocyt
graftversustumor
effect
hematolog
malign
major
histocompat
complexident
allogen
hematopoiet
cell
transplant
hct
result
donor
lymphocyt
activ
minor
histocompat
h
antigen
express
hematopoiet
cell
target
minor
h
antigen
includ
ubiquit
express
antigen
specif
hematopoiet
cell
given
observ
blood
cancer
clinician
quick
explor
whether
allogen
graftversustumor
effect
might
exist
might
therapeut
exploit
variou
metastat
solid
tumor
malign
evalu
includ
colon
breast
prostat
renal
cancer
among
other
outcom
variabl
convinc
graftversustumor
effect
report
minor
patient
colon
renal
cell
cancer
possibl
breast
cancer
wherea
patient
type
malign
shown
respons
previou
work
laboratori
evalu
whether
graftversushost
gvh
reaction
typic
direct
hematopoiet
cell
skin
gut
liver
could
divert
reliabl
includ
metastat
solid
malign
experi
use
canin
hct
model
kidney
serv
surrog
tumor
target
experi
design
determin
whether
adopt
immunotherapi
could
result
reject
specif
organ
ordinarili
involv
gvh
reaction
stabl
mix
chimer
model
maintain
regulatori
cell
could
dislodg
infus
donor
lymphocyt
shift
mix
chimer
alldonor
chimer
induc
graftversushost
diseas
gvhd
donor
lymphocyt
sensit
host
minor
h
antigen
accordingli
mix
chimer
establish
donor
lymphocyt
antigen
dla
ident
litterm
recipi
marrow
donor
underw
transplant
kidney
respect
mix
chimer
recipi
reject
within
week
marrow
donor
lymphocyt
harvest
kidney
graft
reject
inject
recipi
mix
hematopoiet
chimer
convert
full
donor
chimer
although
dog
develop
gvhd
residu
nativ
kidney
express
minor
antigen
use
sensit
donor
target
adopt
transfer
lymphocyt
thu
although
marrow
donor
readili
reject
recipi
kidney
therebi
becam
sensit
mix
chimera
ubiquit
express
minor
h
antigen
evidenc
elimin
host
hematopoiesi
gvhd
level
sensit
appar
insuffici
induc
immunolog
damag
recipi
remain
kidney
investig
question
develop
trichimer
model
marrow
dlaident
litterm
donor
transplant
simultan
third
litterm
condit
gy
total
bodi
irradi
tbi
given
short
cours
postgraft
immunosuppress
kidney
heterotop
transplant
marrow
donor
groin
trichimer
recipi
stabli
accept
serv
solid
organ
surrog
graftversu
tumor
reaction
toward
end
marrow
donor
sensit
h
antigen
marrowkidney
donor
sensit
lymphocyt
subsequ
infus
respect
trichimera
heterotop
locat
kidney
graft
facilit
histolog
monitor
lymphocyt
infiltr
reject
addit
postul
kidney
transplant
would
give
rise
danger
signal
therebi
increas
likelihood
becom
target
lymphocyt
sensit
minor
h
antigen
litter
beagl
beagleminimongrel
mix
rais
fred
hutchinson
cancer
research
center
assess
diseas
receiv
prevent
medicin
program
worm
distemp
parvoviru
adenoviru
type
parainfluenza
viru
corona
viru
rabi
canin
papilloma
viru
dog
age
month
median
month
weigh
kg
median
kg
studi
design
approv
institut
anim
care
use
committe
fred
hutchinson
cancer
research
center
accredit
associ
assess
accredit
laboratori
anim
care
intern
select
donorrecipi
triplet
includ
type
litter
parent
determin
ident
triplet
highli
polymorph
microsatellit
marker
within
dla
class
class
ii
region
confirm
gene
sequenc
day
recipi
treat
gy
tbi
subsequ
iv
infus
marrow
donor
describ
previous
figur
bone
marrow
aspir
humeri
anesthet
donor
vacuum
pump
aspir
brief
skin
humer
head
surgic
prepar
use
steril
techniqu
long
aspir
needl
insert
marrow
caviti
shoulder
joint
needl
connect
surgic
tube
vacuum
flask
contain
heparin
approxim
ml
bloodmarrow
mixtur
collect
per
donor
mixtur
pass
diamet
stainless
steel
mesh
screen
nucleat
marrow
cell
count
correct
white
blood
cell
content
marrow
donor
infus
recipi
cephal
vein
approxim
interv
infus
marrow
graft
individu
donor
figur
schema
gener
trichimer
marrow
recipi
kidney
transplant
reject
gy
tbi
marrow
dlaident
donor
simultan
inject
recipi
postgraft
immunosuppress
csp
mmf
follow
day
respect
b
stabl
trichimer
establish
kidney
transplant
donor
recipi
stabl
kidney
engraft
verifi
donor
sensit
minor
h
antigen
donor
pbmc
inject
dli
sensit
donor
trichimer
recipi
dog
monitor
shift
donor
chimer
gvhd
kidney
graft
reject
contain
median
nucleat
cellskg
rang
dog
receiv
support
postgraft
care
immunosuppress
consist
oral
cyclosporin
csa
mgkg
oral
twice
daili
day
mycophenol
mofetil
mmf
mgkg
sc
twice
daili
day
mmf
dosag
adjust
accord
clinic
toxic
involv
gastrointestin
distress
chimer
analys
conduct
peripher
blood
mononuclear
cell
pbmc
granulocyt
separ
blood
ficol
densiti
marrow
cell
buffer
nh
cl
lysi
red
cell
section
kidney
allograft
collect
necropsi
latter
infiltr
lymphocyt
collect
minc
section
resect
kidney
hour
incub
c
co
method
similar
describ
previous
without
use
enzymat
digest
resect
minc
kidney
tissu
incub
overnight
rpmi
medium
gibcoinvitrogen
carlsbad
ca
plu
heatinactiv
dog
serum
cell
layer
ficol
densiti
centrifug
g
minut
cell
interfac
collect
wash
phosphatebuff
salin
centrifug
contribut
recipi
donor
cell
peripher
blood
hematopoiet
tissu
kidney
quantifi
fluoresc
variablenumb
tandem
repeat
vntr
polymeras
chain
reaction
pcr
analysi
describ
previous
kidney
allograft
marrow
donor
donor
respect
trichimer
marrow
recipi
perform
describ
previous
brief
donor
anesthet
midlin
laparotomi
perform
left
kidney
expos
uret
renal
vein
renal
arteri
secur
transect
kidney
remov
bodi
caviti
perfus
c
salin
contain
uml
heparin
kidney
maintain
cold
heparin
salin
recipi
prepar
surgeri
kidney
subsequ
transplant
trichimer
recipi
right
anterior
thigh
renal
arteri
vein
anastamos
femor
arteri
vein
respect
uret
implant
bladder
kidney
graft
recipi
receiv
immunosuppress
therapi
vascular
transplant
kidney
confirm
ultrason
doppler
flow
detector
park
medic
electron
aloha
least
biopsi
transplant
kidney
perform
studi
complet
tissu
specimen
fix
buffer
formalin
stain
use
hematoxylin
eosin
evalu
microscopi
kidney
volum
calcul
base
techniqu
measur
xenograft
tumor
volum
use
formula
l
w
l
length
w
width
orthogon
measur
kidney
diamet
marrow
donor
sensit
h
antigen
donor
marrow
kidney
donor
use
mean
pbmc
rang
figur
toward
end
ml
blood
collect
kidney
donor
occas
day
apart
half
volum
inject
intraven
half
treat
ammonium
chlorid
lyse
solut
mm
ammonium
chlorid
mm
sodium
bicarbon
mm
edta
wash
inject
subcutan
flank
first
marrow
donor
ten
day
third
inject
leukopheresi
perform
donor
central
venou
cathet
extern
jugular
vein
use
continuousflow
centrifug
cobe
blood
compon
technolog
lakewood
co
three
stabl
hematopoiet
trichimer
dog
receiv
kidney
transplant
marrow
donor
week
marrow
graft
without
postgraft
immunosuppress
dog
hematolog
profil
blood
chemistri
within
normal
rang
tabl
show
host
cell
contribut
time
kidney
transplant
dli
rang
peripher
blood
granulocyt
lymphocyt
hematopoiet
chimer
contribut
marrow
donor
rang
granulocyt
lymphocyt
wherea
marrow
donor
marrow
kidney
respect
popul
two
trichimer
recipi
receiv
immunosuppress
therapi
day
marrow
graft
dog
requir
week
csa
mgkg
taper
mgkg
success
resolut
gvhd
dog
addit
week
elaps
discontinu
csa
kidney
transplant
kidney
neg
lymphocyt
infiltr
week
dli
assess
histolog
examin
needl
biopsi
specimen
measur
kidney
volum
figur
left
column
trichimer
remain
stabl
unchang
kidney
transplant
dli
set
litterm
marrow
donor
sensit
marrowkidney
donor
inject
pbmc
administ
day
apart
ten
day
final
inject
mean
pbmc
rang
harvest
sensit
donor
inject
respect
trichimer
recipi
within
mean
day
dli
rang
day
transplant
kidney
volum
began
increas
trichimer
recipi
exampl
kidney
volum
one
dog
increas
day
data
shown
biopsi
transplant
kidney
reveal
lymphocyt
infiltr
variou
time
point
dli
data
shown
sampl
obtain
necropsi
demonstr
extens
tubul
interstiti
lymphocyt
infiltr
transplant
kidney
consist
acut
sever
reject
figur
middl
column
periglomerular
lymphocyt
infiltr
observ
trichimer
recipi
nativ
kidney
although
infiltr
far
less
pronounc
allogen
kidney
figur
right
column
dog
cell
obtain
cultur
transplant
kidney
tissu
donor
donor
possibl
due
contamin
kidney
cell
data
shown
serum
chemistri
analysi
dli
found
normal
serum
creatinin
blood
urea
nitrogen
level
indic
normal
function
recipi
nativ
kidney
data
shown
dli
dog
trichimer
stabl
month
tabl
dli
rapid
shift
mix
nearli
donor
chimer
occur
dog
within
median
day
rang
day
illustr
dog
figur
dli
donor
contribut
least
hematopoiet
system
recipi
dog
dli
granulocyt
pbmc
donor
domin
hematopoiet
system
shift
trichimer
donor
chimer
also
observ
nucleat
cell
collect
marrow
lymph
node
necropsi
data
shown
peripher
blood
cell
count
chang
significantli
shift
chimer
data
shown
dog
develop
liver
gvhd
indic
serum
level
alkalin
phosphatas
ul
aspart
aminotransferas
ul
alanin
aminotransferas
ul
bilirubin
mgdl
furthermor
skin
gvhd
character
inflammatori
rash
skin
ear
abdomen
nose
oral
mucosa
observ
within
day
dli
dog
within
day
dli
dog
day
dli
dog
dog
develop
diarrhea
lost
weight
diagnosi
gvhd
confirm
histopatholog
dog
euthan
figur
skin
exhibit
chang
rang
minim
infiltr
pbmc
presenc
apoptot
bodi
liver
show
lymphocyt
infiltr
central
venou
region
bile
duct
lesion
confirm
diagnosi
gvhd
atyp
cell
shape
within
bile
duct
indic
cell
regener
jejunum
exhibit
infiltr
pbmc
ileum
dog
reveal
multipl
explod
crypt
crypt
abscess
thu
dog
eventu
develop
acut
gvhd
agvhd
euthan
due
worsen
condit
current
studi
undertaken
aim
target
kidneyan
organ
among
typic
target
gvh
reaction
ie
hematopoiet
system
donat
kidney
trichimer
recipi
donor
underw
apheresi
inject
peripher
blood
donat
donor
apheresi
product
inject
iv
trichimer
recipi
dog
percent
chimer
trichimer
dog
determin
kidney
transplant
dli
time
euthanasia
blood
serum
chemistri
analysi
collect
kidney
transplant
within
week
euthanasia
trichimer
kidney
recipi
gvhd
diagnos
skin
gut
g
liver
l
necropsi
epitheli
cell
skin
gut
liver
mucou
membran
allogen
immun
reaction
studi
prompt
desir
understand
graftversustumor
effect
typic
observ
hematolog
malign
could
extend
includ
metastat
solid
tumor
target
sever
clinic
studi
use
marrow
transplant
treat
variou
metastat
solid
tumor
limit
success
studi
tumoror
tissueassoci
minor
h
antigen
use
sensit
donor
patient
tumor
therefor
would
seem
reason
explor
adopt
immunotherapi
specif
sensit
lymphocyt
achiev
success
treatment
metastat
solid
malign
transplant
tumor
exist
randombr
dog
function
kidney
allograft
uniqu
set
minor
antigen
chosen
surrog
target
impair
kidney
function
could
easili
assess
serum
creatinin
level
histopatholog
examin
percutan
kidney
biopsi
earlier
studi
sensit
canin
marrow
donor
transplant
kidney
respect
mix
hematopoiet
chimer
recipi
promptli
reject
subsequ
lymphocyt
infus
marrow
donor
chimera
caus
convers
mix
donor
chimer
case
gvhd
skin
gut
liver
howev
remain
nativ
kidney
come
immunolog
attack
explain
lack
graftversuskidney
effect
find
strike
contrast
speed
marrow
donor
reject
kidney
chimer
recipi
hypothes
nativ
kidney
lack
appropri
danger
signal
attract
lymphocyt
signal
present
transplant
kidney
model
danger
signal
may
either
constitut
express
case
transplant
induc
stress
hypoxia
trauma
attempt
address
hypothesi
stabl
trichimera
receiv
marrow
graft
figur
kidney
histolog
dog
sensit
dli
necropsi
biopsi
kidney
allograft
done
use
percutan
biopsi
needl
within
week
dli
left
column
section
allograft
middl
column
nativ
kidney
right
column
collect
necropsi
tissu
fix
buffer
formalin
fix
stain
hematoxylin
eosin
photograph
magnif
biol
blood
marrow
transplant
transplant
transplant
dlaident
litterm
kidney
graft
marrow
donor
marrow
donor
kidney
graft
heterotop
put
target
lymphocyt
sensit
minor
h
antigen
case
kidney
stabli
engraft
trichimer
recipi
due
induct
toler
establish
dual
hct
immun
first
marrow
donor
minor
h
antigen
second
marrow
kidney
donor
infus
sensit
lymphocyt
marrow
recipi
immunolog
chain
event
occur
support
part
experiment
assumpt
organ
ordinarili
target
gvhd
reaction
might
target
appropri
experiment
condit
case
allograft
kidney
promptli
becam
infiltr
lymphocyt
sensit
donor
eventu
reject
consist
kidney
allograft
reject
dli
previous
stabl
contribut
marrow
kidney
donor
trichimer
hematopoiesi
disappear
furthermor
perhap
expect
due
share
minor
h
antigen
among
recipi
kidneymarrow
donor
host
hematopoiesi
also
disappear
along
appear
gvhd
classic
target
organ
skin
gut
liver
somewhat
contrast
widespread
immunolog
damag
allograft
kidney
host
skin
gut
liver
host
donor
hematopoiesi
host
nativ
kidney
show
mild
moder
lymphocyt
infiltr
figur
renal
function
impair
find
consist
danger
signal
hypothesi
basi
model
antigenpres
cell
apc
activ
signal
injur
cell
expos
toxin
pathogen
mechan
damag
also
fall
categori
transplant
organ
surgic
ischem
damag
occur
result
activ
antigenpres
cell
thoma
et
al
report
longterm
renal
allograft
establish
histocompat
complexmismatch
macaqu
treat
deoxyspergualin
without
immunotoxin
mutant
diphtheria
toxin
propos
mechan
action
deoxyspergualin
prevent
apc
matur
suppress
express
costimulatori
molecul
establish
state
toler
although
trichimer
model
transplant
kidney
demonstr
stabl
engraft
undetect
molecular
event
may
involv
graftversushost
reaction
dli
transcript
profil
histolog
normal
live
donor
kidney
allograft
park
et
al
found
ongo
injuri
respons
inflamm
posttransplant
upregul
gene
associ
inflamm
immun
respons
injuri
despit
evid
suscept
reject
transplant
kidney
nonetheless
found
limit
infiltr
lymphocyt
within
nativ
kidney
perhap
time
need
renal
function
impair
occur
howev
observ
time
cut
short
develop
lifethreaten
sever
gvhd
skin
gut
liver
nevertheless
clear
success
induc
immun
respons
kidney
tissu
normal
target
gvhd
experi
model
may
shed
light
immunolog
mechan
avert
gvhd
mani
normal
tissu
may
ultim
lead
method
specif
target
respons
solid
tumor
nextgener
sequenc
studi
current
underway
identifi
code
nonsynonym
singlenucleotid
polymorph
breeder
offspr
uniqu
hct
recipi
express
tissu
polymorph
may
display
ubiquit
tissu
express
wherea
other
may
restrict
hematopoiet
cell
individu
organ
kidney
thu
defin
set
h
antigen
could
use
sensit
marrow
donor
candid
target
organ
accordingli
subsequ
dli
would
result
immun
reaction
restrict
desir
target
organ
eg
marrow
kidney
without
develop
gvhd
